From cure to care–understanding long-term health risks after Hodgkin’s lymphoma treatment in adolescents and young adults

Hodgkin’s Lymphoma (HL) is the most common malignancy among Adolescents and Young Adults (AYAs). Although survival rates are excellent, two thirds of survivors experience physical and psychosocial late effects that can emerge years or decades after treatment significantly impacting quality of life. As care priorities shift from cure to survivorship, it is essential that health care professionals (HCPs)—across oncology, primary care, mental health, and general medical services—are equipped to recognise, anticipate, and respond to these long-term consequences. This narrative review examined the evolution of HL treatment in AYAs and explored how these changes influence late-effect risks, with the aim of informing HCP vigilance and clinical practice.